BSE Fundamental Analysis - Balance Sheet & Share Holding Pattern

EARUMPHARMACEUTICALS01 Jan 1900

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in

EARUMPHARMACEUTICALS01 Jan 1900

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
08-Oct-2021	S	Board approves split of shares of the Company Earum Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here (As Per BSE Announcement Dated 11.11.2021) Trading Members of the Exchange are hereby informed that EARUM PHARMACEUTICALS LTD. has fixed the Record Date for the purpose of sub division of equity shares of the company. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE EARUM PHARMACEUTICALS LTD. (542724) RECORD DATE 18/12/2021 PURPOSE Sub Division of existing equity shares from every One equity share of Rs. 10/- each into Five equity shares of Rs. 2/- each. SUB-DIVIDED PAID-UP VALUE Rs.2/- SUB-DIVIDED PAID-UP VALUE W.E.F. 16/12/2021 DR-178/2021-2022 Note:- i. ISIN No. INE060601015 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 16/12/2021. ii. The new ISIN Number for Rs.2/- paid up will be informed to the market by a separate notice. (As Per BSE Notice Dated on 30.11.2021) In Continuation of Notice No. 20211130-57 dated November 30, 2021, Trading Members of the Exchange are hereby informed that the New ISIN number for the equity shares of the company will be as under: - Company Name & Scrip Code EARUM PHARMACEUTICALS LTD. (542724) New ISIN No. INE060601023 Remarks Sub-division of equity shares from Rs.10/- to Rs.2/- The new ISIN number given above, for Equity Shares of Rs.2/- each of the company shall be effective for trades done on and from the Ex-Date i.e. 16-12-2021 (DR-178/2021-2022) (As Per BSE Notice Dated on 09.12.2021)	18-Dec-2021
30-Jul-2021	B	1:1 Bonus Issue of Equity Shares Trading Members of the Exchange are hereby informed that, Earum Pharmaceuticals Limited has fixed the record date for the purpose of Bonus Issue. The transactions in the equity shares of the company would be on an ex-bonus basis with effect from the under mentioned date. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Earum Pharmaceuticals Limited (542724) RECORD DATE 10/08/2021 PURPOSE Issue of 1 (One) Bonus equity shares of Rs.10/- each for every 1 (One) existing equity share of Rs.10/- each held. Ex-Bonus basis from Date & Sett. No. 09/08/2021 DR-090/2021-2022 Trading Members are requested to note the change in the market lot of Earum Pharmaceuticals Limited (542724) pursuant to the Bonus Issue of equity shares as given below, which will be effective from Tuesday, August 10, 2021: Scrip Code 542724 Scrip Name Earum Pharmaceuticals Limited Current Market Lot 1500 Revised Market Lot 3000 (As Per BSE Notice Dated on 30.07.2021)	10-Aug-2021	1:1
31-Mar-2023	R	4:1 Right Issue of Equity Shares Trading Members of the Exchange are hereby informed that Earum Pharmaceuticals Limited has fixed Record Date for the purpose of Rights Issue of Equity Shares. The transactions in the Equity Shares of the Company should be done on Ex-Rights basis with effect from the under mentioned date :- DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Earum Pharmaceuticals Limited (542724) RECORD DATE 10.04.2023 PURPOSE Issue of 04 (Four) Equity Shares of Rs.2/- each for cash at Par on Rights Basis for every 01 (One) Equity Share of Rs.2/- held. Ex-Right basis from Date & Sett. No. 10/04/2023 DR-505/2023-2024 Trading Members of the Exchange are requested to take note of it. (As Per BSE Notice Dated on 03.04.2023)	10-Apr-2023	4:1
29-Mar-2024	BC	Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Meeting Board of Directors of the Company held today i.e., Frid	24-Apr-2024
04-Apr-2024	BC	Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Meeting Board of Directors of the Company was held today i.e.,	04-Apr-2024
04-Apr-2024	BC	Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Meeting Board of Directors of the Company was held today i.e.,	04-Apr-2024
29-Mar-2024	BC	Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Meeting Board of Directors of the Company held today i.e., Frid	29-Mar-2024
29-Mar-2024	BC	Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Meeting Board of Directors of the Company held today i.e., Frid	29-Mar-2024

Record Date01 Jan'1900

Ex-Rights Date01 Jan'1900

Premium(Rs.)0

Ratio4:1

Book Closure

Record Date	Split Date	Purpose
24-Apr-2024	-	Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Meeting Board of Directors of the Company held today i.e., Frid
04-Apr-2024	-	Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Meeting Board of Directors of the Company was held today i.e.,
04-Apr-2024	-	Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Meeting Board of Directors of the Company was held today i.e.,
29-Mar-2024	-	Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Meeting Board of Directors of the Company held today i.e., Frid
29-Mar-2024	-	Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Meeting Board of Directors of the Company held today i.e., Frid

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Integra Essentia Ltd ₹4.45(+0.20/4.71%)	4.45	+0.20	406.76	27.87	26.59	3.53
Kothari Products Ltd ₹136.25(+2.15/1.60%)	136.25	+2.15	406.62	18.27	81.01	0.42
Visagar Polytex Ltd ₹1.00(0.00/0.00%)	1.00	+0.00	29.27	11.11	0.00	1.82
Hexa Tradex Ltd ₹151.65(+0.60/0.40%)	151.65	+0.60	837.87	2.74	0.00	0.33
Future Consumer Ltd ₹0.90(0.00/0.00%)	0.90	+0.00	179.73	-25.00	0.00	-0.78

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	0.40	0.43	1.71	1.53	1.17	7.11
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.40	0.43	1.71	1.53	1.17	7.11
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.00	0.66	0.00	1.40	0.00
Total Income	0.40	0.43	2.37	1.53	2.56	7.11
Total Expenditure	0.35	1.38	2.38	0.33	1.03	7.05
PBIDT	0.06	-0.95	0.00	1.20	1.54	0.06
Interest	0.00	0.01	0.26	0.15	0.14	0.00
PBDT	0.06	-0.96	-0.26	1.06	1.39	0.06
Depreciation	0.02	0.02	0.02	0.03	0.03	0.02
Tax	0.00	-0.11	0.00	0.26	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	0.04	-0.87	-0.28	0.77	1.37	0.04
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.04	-0.87	-0.28	0.77	1.37	0.04

EPS (Unit Curr.)	0.00	-0.04	0.00	0.04	0.22	0.00
EPS (Adj) (Unit Curr.)	0.00	-0.04	0.00	0.03	0.19	0.00
Calculated EPS (Unit Curr.)	0.00	-0.04	-0.01	0.12	0.22	0.01
Calculated EPS (Adj) (Unit Curr.)	0.00	-0.04	-0.01	0.10	0.19	0.01
Calculated EPS (Ann.) (Unit Curr.)	0.01	-0.14	-0.05	0.50	0.89	0.02
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.01	-0.14	-0.05	0.42	0.75	0.02
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	49.42	49.42	49.42	12.34	12.34	12.34
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	2.00	2.00	2.00	2.00	2.00	2.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	15.00	-220.93	0.00	78.43	131.62	0.84
PBDTM(%)	15.00	-223.26	-15.20	69.28	118.80	0.84
PATM(%)	10.00	-202.33	-16.37	50.33	117.09	0.56

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	12.34	12.34	6.17	6.17	0.31	0.31
Reserves Total	6.37	4.39	8.33	8.25	5.64	4.08
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.53
Total Shareholders Funds	18.71	16.73	14.50	14.42	5.95	4.92
Secured Loans	8.74	8.74	8.95	7.45	5.80	5.09
Unsecured Loans	0.00	0.00	2.38	1.83	3.78	2.12
Total Debt	8.74	8.74	11.33	9.28	9.58	7.21
Total Liabilities	27.45	25.47	25.83	23.70	15.53	12.13
APPLICATION OF FUNDS :
Gross Block	0.95	0.95	1.09	1.00	0.48	0.26
Less : Accumulated Depreciation	0.48	0.37	0.33	0.21	0.00	0.07
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.47	0.58	0.76	0.79	0.48	0.19
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	3.03	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	13.13	12.25	15.46	13.39	10.93	8.29
Sundry Debtors	8.39	15.04	10.67	16.95	10.85	10.79
Cash and Bank	0.03	0.05	0.06	0.03	0.16	0.02
Loans and Advances	6.56	0.87	0.91	1.96	0.84	0.21
Total Current Assets	28.11	28.21	27.11	32.33	22.78	19.31
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	-0.77	2.29	1.64	11.82	6.82	7.05
Provisions	1.90	1.03	0.38	0.64	0.89	0.33
Total Current Liabilities	1.13	3.32	2.03	12.45	7.72	7.38
Net Current Assets	26.98	24.89	25.08	19.88	15.06	11.94
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.01	0.01	0.01	0.01	0.01	0.01
Net Deferred Tax	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01
Total Assets	27.45	25.46	25.83	23.70	15.53	12.13
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.05	0.06	0.03	0.16	0.02
Net Cash from Operating Activities	0.26	2.61	-7.10	-3.45	-0.48
Net Cash Used In Investing Activities	0.00	0.06	2.94	-3.45	-0.32
Net Cash Used In Financing Activities	-0.29	-2.67	2.90	6.76	0.94
Net Inc./Dec In Cash And Cash Equivalents	-0.03	-0.01	-1.26	-0.14	0.14
Cash And Cash Equivalents At End Of The Year	0.03	0.05	-1.24	0.03	0.16

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

0.00%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

100.00%

**Promoter pledged shareholding 0.00%

About Murae Organisor Ltd

Murae Organisor Ltd is in the Trading sector, having a market capitalization of Rs. 38.8 crores. It has reported a sales of Rs. 0.4 crores and a net profit of Rs. 0.04 crores for the quarter ended December 2018. The company management includes , Bhumishth Narendrabhai Patel,Payal Bhumishth Patel,Bhavik Shantilal Patel,Dahyabhai Mafatlal Patel,Parimal S Patwa,Harsh M Kothari,Madhuri Mistry,Sumitkumar Patel,Premaram Patel,Sanjaykumar Nai,Vijaykumar Patel,Tilva Manthan (Murae Organisor Ltd) among others.

Chairman

Registered office

G1 Ground Floor VR Complex,Nr Sanathal Cross Rd SP RingRd,Ahmedabad,Gujarat,382210

FAX :

Background

Incorporation Year2012

Face Value₹2

Market Lot1

How to buy shares on nse?

To buy shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the share price today?

The shares price on nse is Rs.0 today.

What is the market cap of shares on ?

The company has a market capitalization of Rs.0.00Cr

What is the PE & PB ratio of shares ?

PE is 0 and PB is 0

What is the 52 Week High and Low of shares?

stock price high: Rs.0 stock price low: Rs.0